The use of glucagon-like peptide-1 receptor agonists or GLP-1RAs has increased dramatically, but recommendations suggest their discontinuation before pregnancy because theres not enough information about their safety for unborn babies, Dr
The prospective, randomized, placebo-controlled design of the trial together with the gold standard methods used for insulin sensitivity and GFR measurements in a subgroup of patients are the major strength of our study
28 (7-8):753-6 Yasushi Honda, Takaomi Kessoku, Yoshio Sumida, Takashi Kobayashi, Takayuki Kato, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Koji Fujita, Masato Yoneda, Koshi Kataoka, Masataka Taguri, Takeharu Yamanaka, Yuya Seko, Saiyu Tanaka, Satoru Saito, Masafumi Ono, Satoshi Oeda, Yuichiro Eguchi, Wataru Aoi, Kenji Sato, Yoshito Itoh, and Atsushi Nakajima - Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study - BMC Gastroenterol
DISCLAIMER If you have any medical questions or concerns, please talk to your healthcare provider
Note: Be wary of compound versions
